NEW YORK, NY / ACCESS Newswire / February 21, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of West ...

West Pharmaceutical Services is down 39.2% since the beginning of the year, and at $199.74 per share, it is trading 51.1% below its 52-week high of $408.19 from February 2024.

West Pharmaceutical Services (WST) stock plummeted 38% on Thursday, making it the biggest decliner in the S&P 500. The sharp drop followed the company’s 2025 full-year profit and revenue ...

West Pharmaceutical Services Inc. closed 47.37% below its 52-week high of $400.88, which the company reached on March 21st.

Deutsche Bank upgraded West Pharmaceutical Services (NYSE:WST) to Buy from Hold on Friday, even after the contract drug manufacturer witnessed a ~38% drop in the previous session following a worse ...

EXTON, Pa. (AP) — EXTON, Pa. (AP) — West Pharmaceutical Services Inc. (WST) on Thursday reported fourth-quarter profit of $130.1 million. The Exton, Pennsylvania-based company said it had net ...

West Pharmaceutical Services Inc.’s stock tumbled 33% Thursday, to lead S&P 500 decliners, after the manufacturer of injectable-pharmaceutical packaging and delivery systems offered guidance for ...

Investors with a lot of money to spend have taken a bullish stance on West Pharmaceutical Servs (NYSE:WST). And retail traders should know. We noticed this today when the trades showed up on ...

Shares of healthcare products company West Pharmaceutical Services (NYSE:WST) fell 34.9% in the afternoon session after the company reported disappointing fourth-quarter 2024 results: its full-year ...

Healthcare products company West Pharmaceutical Services (NYSE:WST) will be reporting earnings tomorrow morning. Here’s what to look for. West Pharmaceutical Services beat analysts’ revenue ...